PRG4 and arthritic joint disease: Analysis of SF subset enrichment across different pathologies [14] revealed an amplified ratio of PRG4+THY1- SFs in myelopathological and lymphoid types compared to rhabdomyosarcoma types, indicating strong influence from immune cells on PRG4+ gene expression in synovial membranes involved in arthritis development [14].